Lista de obras -

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

artículo científico publicado en 2015

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

artículo científico publicado en 2016

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

artículo científico publicado en 2013

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

artículo científico publicado en 2018

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

artículo científico publicado en 2017

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

artículo científico publicado en 2017

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

artículo científico publicado en 2014

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?

artículo científico publicado en 2020

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

artículo científico publicado en 2018

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

artículo científico publicado en 2016

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

scientific article published on 06 December 2019

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

artículo científico publicado en 2019

Ectopic pregnancy treatment by combination therapy.

artículo científico publicado en 2016

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

artículo científico publicado en 2018

Evaluation of indications for amniocentesis in cases of normal fetal ultrasound results

artículo científico publicado en 2020

Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids

scientific article published on 01 January 2019

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

artículo científico publicado en 2017

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

artículo científico publicado en 2014

Herlyn-Werner-Wunderlich Syndrome: Comparison of Two Cases

scientific article published on 30 September 2020

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

artículo científico publicado en 2017

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

artículo científico publicado en 2016

New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.

artículo científico publicado en 2016

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

artículo científico publicado en 2016

Risk Model in Women with Ovarian Cancer Without Mutations

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

artículo científico publicado en 2014

Sexuality of Women after Gynecological Surgeries

artículo científico publicado en 2020

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

artículo científico publicado en 2018

The Role of Zinc and Copper in Gynecological Malignancies

artículo científico publicado en 2020

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients

artículo científico publicado en 2020

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes

artículo científico publicado en 2019

The temporal link between prenatal steroid therapy and labor

artículo científico publicado en 2020

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

artículo científico publicado en 2017

Lista de obras de

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

Ectopic pregnancy treatment by combination therapy.

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

Evaluation of indications for amniocentesis in cases of normal fetal ultrasound results

Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

Herlyn-Werner-Wunderlich Syndrome: Comparison of Two Cases

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

Risk Model in Women with Ovarian Cancer Without Mutations

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

Sexuality of Women after Gynecological Surgeries

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

The Role of Zinc and Copper in Gynecological Malignancies

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes

The temporal link between prenatal steroid therapy and labor

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.